Mirum Pharmaceuticals Inc

NASDAQ:MIRM   3:59:59 PM EDT
14.09
+0.84 (+6.34%)
Earnings Announcements

Mirum Pharmaceuticals Reports Q3 Loss Per Share $1.55

Published: 11/15/2021 21:33 GMT
Mirum Pharmaceuticals Inc (MIRM) - Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $1.55.
Q3 Earnings per Share View $-1.73 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $59.81 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $6.37 Million
Next Quarter EPS Guidance is expected to be -$1.58

More details on our Analysts Page.